Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: A meta-analysis

Molecular Genetics and Metabolism

Volumn 103, Issue 4, 2011, Pages 388-393

  Yao, Yao ^a,b   Ma, Cai hong ^a   Tang, Hui lin ^a   Hu, Yong fang ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

FSHR; IVF; Meta analysis; Single nucleotide polymorphism

Indexed keywords

ASPARAGINE; FOLLITROPIN RECEPTOR; SERINE;

ADULT; ARTICLE; ASIAN; CAUCASIAN; DRUG DOSE; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; META ANALYSIS; OOCYTE; OVARY FUNCTION; PREGNANCY RATE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FERTILIZATION IN VITRO; GENOTYPE; HUMANS; OVARY; POLYMORPHISM, GENETIC; PREGNANCY; RECEPTORS, FSH; SERINE; TREATMENT OUTCOME;

EID: 79960847588     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.04.005     Document Type: Article

References (26)

1. Salha O., Balen A.H. New concepts in superovulation strategies for assisted conception treatments. Curr. Opin. Obstet. Gynecol. 2000, 12:201-206.
2. Jones H.W. The use of controlled ovarian hyperstimulation (COH) in clinical in vitro fertilization: the role of Georgeanna Seegar Jones. Fertil. Steril. 2008, 90:e1-e3.
3. Enskog A., Henriksson M., Unander M., Nilsson L., Brännström M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil. Steril. 1999, 71:808-814.
4. Simoni M., Gromoll J., Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr. Rev. 1997, 18:739-773.
5. Aittomaki K., Lucena J.L., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., Kaskikari R., Sankila E.M., Lehvaslaiho H., Engel A.R., Nieschlag E., Huhtaniemi I., de la Chapelle A. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995, 82:959-968.
6. Loutradis D., Vlismas A., Drakakis P., Antsaklis A. Pharmacogenetics in ovarian stimulation-current concepts. Ann. N.Y. Acad. Sci. 2008, 1127:10-19.
7. Perez Mayorga M., Gromoll J., Behre H.M., Gassner C., Nieschlag E., Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J. Clin. Endocrinol. Metab. 2000, 85:3365-3369.
8. Sudo S., Kudo M., Wada S., Sato O., Hsueh A.J., Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol. Hum. Reprod. 2002, 8:893-899.
9. de Castro F., Ruiz R., Montoro L., Perez-Hernandez D., Sanchez-Casas Padilla E., Real L.M., Ruiz A. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil. Steril. 2003, 80:571-576.
10. Klinkert E.R., te Velde E.R., Weima S., van Zandvoort P.M., Hanssen R.G., Nilsson P.R., de Jong F.H., Looman C.W., Broekmans F.J. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod. Biomed. Online 2006, 13:687-695.
11. Achrekar S.K., Modi D.N., Desai S.K., Mangoli V.S., Mangoli R.V., Mahale S.D. Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women. Fertil. Steril. 2009, 91:432-439.
12. Chowbay B., Li H., David M., Cheung Y.B., Lee E.J. Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression. Br. J. Clin. Pharmacol. 2005, 60:159-171.
13. Behre H.M., Greb R.R., Mempel A., Sonntag B., Kiesel L., Kaltwasser P., Seliger E., Ropke F., Gromoll J., Nieschlag E., Simoni M. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet. Genomics 2005, 15:451-456.
14. Jun J.K., Yoon J.S., Ku S.Y., Choi Y.M., Hwang K.R., Park S.Y., Lee G.H., Lee W.D., Kim S.H., Kim J.G., Moon S.Y. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J. Hum. Genet. 2006, 51:665-670.
15. Loutradis D., Patsoula E., Minas V., Koussidis G.A., Antsaklis A., Michalas S., Makrigiannakis A. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J. Assist. Reprod. Genet. 2006, 23:177-184.
16. Moron F.J., Ruiz A. Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers. Pharmacogenomics 2010, 11:1613-1618.
17. Tinkanen H., Blauer M., Laippala P., Tuohimaa P., Kujansuu E. Prognostic factors in controlled ovarian hyperstimulation. Fertil. Steril. 1999, 72:932-936.
18. Imani B., Eijkemans M.J., Faessen G.H., Bouchard P., Giudice L.C., Fauser B.C. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil. Steril. 2002, 77:83-90.
19. de Koning C.H., Benjamins T., Harms P., Homburg R., van Montfrans J.M., Gromoll J., Simoni M., Lambalk C.B. The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles. Hum. Reprod. (Oxford, England) 2006, 21:443-446.
20. Kuijper E.A., Blankenstein M.A., Luttikhof L.J., Roek S.J., Overbeek A., Hompes P.G., Twisk J.W., Lambalk C.B. Frequency distribution of polymorphisms in the FSH receptor gene in infertility patients of different ethnicity. Reprod. Biomed. Online 2010, 20:588-593.
21. Livshyts G., Podlesnaja S., Kravchenko S., Sudoma I., Livshits L. A distribution of two SNPs in exon 10 of the FSHR gene among the women with a diminished ovarian reserve in Ukraine. J. Assist. Reprod. Genet. 2009, 26:29-34.
22. Dipple K.M., Phelan J.K., McCabe E.R.B. Consequences of complexity within biological networks: robustness and health, or vulnerability and disease. Mol. Genet. Metab. 2001, 74:45-50.
23. Georgiou I., Konstantelli M., Syrrou M., Messinis I.E., Lolis D.E. Oestrogen receptor gene polymorphisms and ovarian stimulation for in-vitro fertilization. Hum. Reprod. 1997, 12:1430-1433.
24. Sundarrajan C., Liao W., Roy A.C., Ng S.C. Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF. Mol. Hum. Reprod. 1999, 5:797-802.
25. de Castro F., Moron F.J., Montoro L., Galan J.J., Hernandez D.P., Padilla E.S., Ramirez-Lorca R., Real L.M., Ruiz A. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 2004, 14:285-293.
26. Moron F.J., de Castro F., Royo J.L., Montoro L., Mira E., Saez M.E., Real L.M., Gonzalez A., Manes S., Ruiz A. Bone morphogenetic protein 15. Pharmacogenet. Genomics 2006, 16:485-495.